BIOTANGENTS LIMITED

SC495625
Active Penicuik

Other professional, scientific and technical activities n.e.c.

12 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
B

BIOTANGENTS LIMITED

SC495625

Other professional, scientific and technical activities n.e.c.

Founded 21 Jan 2015 Active Penicuik, Scotland 12 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
Accounts Submitted 22 Apr 2025 Next due 30 Sept 2026 3 months remaining
Confirmation Submitted 17 Mar 2026 Next due 3 Feb 2027 7 months remaining
Net assets £1M £704K 2024 year on year
Total assets £3M £790K 2024 year on year
Total Liabilities £2M £86K 2024 year on year
Charges 1
1 outstanding

Contact & Details

Contact

Registered Address

Unit 14/15 Doherty Innovation Centre Pentland Science Park Bush Loan Penicuik EH26 0PZ Scotland

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for BIOTANGENTS LIMITED (SC495625), an active life sciences and medical technology company based in Penicuik, Scotland. Incorporated 21 Jan 2015. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type total-exemption-full
Next accounts 31 Dec 2025
Due by 30 Sept 2026 3 months remaining

Net Assets, Total Assets & Total Liabilities (2015–2024)

Cash in Bank

£1.25M

Increased by £1.23M (+5381%)

Net Assets

£1.22M

Decreased by £704.07k (-37%)

Total Liabilities

£2.11M

Decreased by £86.05k (-4%)

Turnover

N/A

Employees

12

Debt Ratio

63%

Increased by 10 (+19%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 4
Grants 3

Investors (6)

Investor NameInvestor SinceParticipating Rounds
Investor 1May 2019Seed
Investor 2May 2019Seed, Series A
Investor 3May 2022Seed, Series A

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 67,036 Shares £6.46m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
13 Jan 202613,180£976k£74.08
31 Oct 202435,676£2.64m£74.08
28 Aug 20243,270£242k£74.08
25 Aug 2023779£138k£177.31
23 Dec 20222,604£462k£177.31

Officers

Officers

1 active 2 resigned
Status
Kring, OleDirectorDanishDenmark631 Mar 2021Active

Shareholders

Shareholders (101)

Mnl Nominees Limited
18.4%
16,733
Scottish Enterprise
14.5%
13,207

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Alan Norman Hale

Ceased 31 Aug 2022

Ceased

Andrew Mark Hall-ponselè

Ceased 28 Oct 2022

Ceased

Lina Gasiunaite

Ceased 6 Oct 2022

Ceased

Group Structure

Group Structure

No group structure identified

Charges

Charges

1 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
17 Mar 2026Confirmation StatementConfirmation statement made on 20 Jan 2026 with updates
26 Jan 2026OfficersAppointment of Dr Simon Eric Aspland as director on 13 Jan 2026
19 Jan 2026OfficersTermination of Fiona Anne Marshall as director on 24 Dec 2025
16 Jan 2026CapitalAllotment of shares (GBP 909.96) on 13 Jan 2026
22 Apr 2025AccountsAnnual accounts made up to 31 Dec 2024
17 Mar 2026 Confirmation Statement

Confirmation statement made on 20 Jan 2026 with updates

26 Jan 2026 Officers

Appointment of Dr Simon Eric Aspland as director on 13 Jan 2026

19 Jan 2026 Officers

Termination of Fiona Anne Marshall as director on 24 Dec 2025

16 Jan 2026 Capital

Allotment of shares (GBP 909.96) on 13 Jan 2026

22 Apr 2025 Accounts

Annual accounts made up to 31 Dec 2024

Recent Activity

Latest Activity

Confirmation statement made on 20 Jan 2026 with updates

3 months ago on 17 Mar 2026

Appointment of Dr Simon Eric Aspland as director on 13 Jan 2026

4 months ago on 26 Jan 2026

Termination of Fiona Anne Marshall as director on 24 Dec 2025

5 months ago on 19 Jan 2026

Allotment of shares (GBP 909.96) on 13 Jan 2026

5 months ago on 16 Jan 2026

Annual accounts made up to 31 Dec 2024

1 years ago on 22 Apr 2025